JP Morgan analyst Jose Asumendi initiates coverage on QuantumScape (NYSE:QS) with a Neutral rating and announces Price Target of $35.
ShockWave Medical Q3 EPS $0.92 Beats $0.67 Estimate, Sales $131.33M Beat $123.97M Estimate
ShockWave Medical (NASDAQ:SWAV) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.67 by 37.31 percent. This is a 1740 percent increase over earnings of $0.05 per share from